Vaccine adjuvant materials for cancer immunotherapy and control of infectious disease.

Author: Yong Taik LIM ¹
Author Information

1. SKKU Advanced Institute of Nanotechnology, School of Chemical Engineering, Sungkyunkwan University, Suwon, Korea. yongtaik@skku.edu
Publication Type:Review
Keywords: Immunological adjuvants; Immunotherapy; Immunomodulation
MeSH: Adjuvants, Immunologic; Allergy and Immunology; Communicable Diseases*; Immune System; Immunomodulation; Immunotherapy*
From:Clinical and Experimental Vaccine Research 2015;4(1):54-58
CountryRepublic of Korea
Language:English
Abstract: Adjuvants can be defined as pharmacological and immunological components that are able to modify and/or enhance antigen-specific immune responses. Based on the interdisciplinary research between immunology and material science/engineering, various vaccine adjuvant materials have been developed. By rational design and engineering of antigen or adjuvant materials, immune-modulatory vaccine systems generated to activate immune system. Here, we review the current progress of bioengineered prophylactic and/or therapeutic vaccine adjuvant for cancer and/or infectious disease, and discuss the prospect of future vaccine adjuvant materials.